Clinical Trial Location: International

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

https://clinicaltrials.gov/study/NCT06517732

The Living With a Long-Term Condition Study

https://clinicaltrials.gov/study/NCT06072287

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

https://clinicaltrials.gov/study/NCT05889182

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

https://clinicaltrials.gov/study/NCT06468228

The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.

https://clinicaltrials.gov/study/NCT05913817

Patient’s Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

https://clinicaltrials.gov/study/NCT06444087

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

https://clinicaltrials.gov/study/NCT05921994

A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

https://clinicaltrials.gov/study/NCT06028230

1 2